Burying The ‘Not Your Parents’ Cannabis’ Cliché Once And For All | Talking Joints Memo
The focus on cannabis dosing guidelines is essential to understanding therapeutic outcomes. Proper patient education on THC potency helps ensure clinical safety. This article debunks myths about modern cannabis potency and emphasizes dosing.
Are Seniors Being Used as CBD Guinea Pigs in CMS Program?
The 2026 cannabis clinical safety of seniors in CMS CBD programs is under scrutiny due to potential drug interactions and unique geriatric considerations. This emerging Medicare policy shift could impact older adults' access to cannabis medicine. Careful…
Possible Drug–Drug Interactions Between Cannabinoids and Candidate COVID-19 Drugs
Cannabinoids drug interactions with COVID-19 therapeutics are an emerging clinical concern. Understanding cytochrome P450 enzyme involvement is essential for safe prescribing. Patients should disclose cannabis use when receiving COVID treatments.
